Bradley W. Caprathe

958 total citations
25 papers, 781 citations indexed

About

Bradley W. Caprathe is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bradley W. Caprathe has authored 25 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bradley W. Caprathe's work include Receptor Mechanisms and Signaling (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (3 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Bradley W. Caprathe is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (3 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Bradley W. Caprathe collaborates with scholars based in United States and Germany. Bradley W. Caprathe's co-authors include Juan C. Jaén, Lawrence D. Wise, Thomas A. Pugsley, Thomas G. Heffner, Leonard T. Meltzer, Haile Tecle, Christine Humblet, Stephen C. Bergmeier, John L. Gilmore and Sheryl J. Hays and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bradley W. Caprathe

25 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bradley W. Caprathe United States	14	558	299	77	61	48	25	781
G. Kumaravel United States	18	518 0.9×	575 1.9×	67 0.9×	57 0.9×	52 1.1×	36	975
Michael S. Dappen United States	12	354 0.6×	186 0.6×	55 0.7×	57 0.9×	56 1.2×	17	521
Juan A. Vega United States	16	749 1.3×	284 0.9×	98 1.3×	66 1.1×	71 1.5×	29	966
Maria J. Mokrosz Poland	18	507 0.9×	428 1.4×	173 2.2×	38 0.6×	31 0.6×	59	799
E. FERNANDEZ‐ALVAREZ Spain	18	566 1.0×	205 0.7×	78 1.0×	110 1.8×	46 1.0×	52	786
David Middlemiss United Kingdom	20	624 1.1×	337 1.1×	117 1.5×	54 0.9×	36 0.8×	45	993
A. DA SETTIMO Italy	17	637 1.1×	348 1.2×	54 0.7×	57 0.9×	33 0.7×	64	841
Brian A. McKittrick United States	16	396 0.7×	306 1.0×	56 0.7×	101 1.7×	105 2.2×	43	714
A. Walser United States	16	434 0.8×	269 0.9×	134 1.7×	47 0.8×	37 0.8×	55	792
David J. Hallett United Kingdom	17	478 0.9×	390 1.3×	124 1.6×	72 1.2×	81 1.7×	26	906

Countries citing papers authored by Bradley W. Caprathe

Since Specialization

Citations

This map shows the geographic impact of Bradley W. Caprathe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley W. Caprathe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley W. Caprathe more than expected).

Fields of papers citing papers by Bradley W. Caprathe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley W. Caprathe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley W. Caprathe. The network helps show where Bradley W. Caprathe may publish in the future.

Co-authorship network of co-authors of Bradley W. Caprathe

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley W. Caprathe. A scholar is included among the top collaborators of Bradley W. Caprathe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley W. Caprathe. Bradley W. Caprathe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galatsis, Paul, Bradley W. Caprathe, John L. Gilmore, et al.. (2010). Succinic acid amides as P2–P3 replacements for inhibitors of interleukin-1β converting enzyme (ICE or caspase 1). Bioorganic & Medicinal Chemistry Letters. 20(17). 5184–5190. 16 indexed citations

Galatsis, Paul, Bradley W. Caprathe, Dennis M. Downing, et al.. (2010). Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones. Bioorganic & Medicinal Chemistry Letters. 20(17). 5089–5094. 6 indexed citations

Caprathe, Bradley W., Michael J. Callahan, James M. Graham, et al.. (2008). The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(3). 654–657. 38 indexed citations

Harter, William G., H. Albrecht, Kenneth D. Brady, et al.. (2004). The Design and Synthesis of Sulfonamides as Caspase‐1 Inhibitors.. ChemInform. 35(23). 1 indexed citations

Harter, William G., Kenneth D. Brady, Bradley W. Caprathe, et al.. (2003). The design and synthesis of sulfonamides as caspase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(3). 809–812. 53 indexed citations

Tecle, Haile, Roy D. Schwarz, Stephen D. Barrett, et al.. (2000). CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology. Pharmaceutica Acta Helvetiae. 74(2-3). 141–148. 11 indexed citations

Barrett, Stephen D., Juan C. Jaén, Bradley W. Caprathe, Anthony J. Thomas, & Haile Tecle. (1997). EFFICIENT SYNTHESIS OFEXO-1-AZABICYCLO[2.2.1]HEPTAN-3-OL. Organic Preparations and Procedures International. 29(3). 330–335. 3 indexed citations

Pool, William F., Thomas F. Woolf, Michael D. Reily, et al.. (1996). Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology. Journal of Medicinal Chemistry. 39(15). 3014–3018. 12 indexed citations

Jaén, Juan C., Edgardo Laborde, Bradley W. Caprathe, et al.. (1995). Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF Receptor. Journal of Medicinal Chemistry. 38(22). 4439–4445. 23 indexed citations

10.

Spiegel, K., Dimitris K. Agrafiotis, Bradley W. Caprathe, et al.. (1995). PD-90780, a Nonpeptide Inhibitor of Nerve Growth Factor′s Binding to the P75 NGF Receptor. Biochemical and Biophysical Research Communications. 217(2). 488–494. 22 indexed citations

11.

Wright, Jon L., Bradley W. Caprathe, Dennis M. Downing, et al.. (1994). The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 37(21). 3523–3533. 18 indexed citations

12.

Meltzer, Leonard T., Bradley W. Caprathe, Curt Christoffersen, et al.. (1993). Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1177–1189. 2 indexed citations

13.

Jaén, Juan C., Bradley W. Caprathe, Thomas A. Pugsley, Lawrence D. Wise, & Hyacinth C. Akunne. (1993). Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors. Journal of Medicinal Chemistry. 36(24). 3929–3936. 26 indexed citations

14.

Jaén, Juan C., et al.. (1991). Synthesis of the Enantiomers of Reduced Haloperidol. Pharmaceutical Research. 8(8). 1002–1005. 15 indexed citations

15.

Caprathe, Bradley W., Juan C. Jaén, Lawrence D. Wise, et al.. (1991). Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine. Journal of Medicinal Chemistry. 34(9). 2736–2746. 31 indexed citations

16.

Jaén, Juan C., Bradley W. Caprathe, Lawrence D. Wise, et al.. (1991). Novel 4,5,6,7-tetrahydrobenzothiazole dopamine agonists display very low stereoselectivity in their interaction with dopamine receptors.. Bioorganic & Medicinal Chemistry Letters. 1(4). 189–192. 4 indexed citations

17.

Jaén, Juan C., Bradley W. Caprathe, Lawrence D. Wise, et al.. (1991). Synthesis and dopaminergic activity of the enantiomers of 6-methyl-4,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine (PD 128483).. Bioorganic & Medicinal Chemistry Letters. 1(10). 539–544. 5 indexed citations

18.

Jaén, Juan C., Lawrence D. Wise, Bradley W. Caprathe, et al.. (1990). 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties. Journal of Medicinal Chemistry. 33(1). 311–317. 229 indexed citations

19.

Butler, Donald E., et al.. (1987). Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 30(3). 498–503. 46 indexed citations

20.

Lebel, Norman A. & Bradley W. Caprathe. (1985). Nitrones by heterolytic fragmentation of .gamma.-N-hydroxyamino sulfonates. Conversion of a decahydroquinoline to a perhydroazaazulene. The Journal of Organic Chemistry. 50(20). 3938–3940. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact